References
- Milewicz A, Jedrzejuk D. Premenstrual syndrome: from etiology to treatment. Maturitas 2006;55s:S47–S54.
- Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001;185:227–35.
- Siahbazi S, Behboudi-Gandevani S, Moghaddam-Banaem L, Montazeri A. Effect of zinc sulfate supplementation on premenstrual syndrome and health-related quality of life: clinical randomized controlled trial. J Obstet Gynaecol Res 2017. [Epub ahead of print]. doi: 10.1111/jog.13299.
- Usman SB, Indusekhar R, O’Brien S. Hormonal management of premenstrual syndrome. Best Pract Res Clin Obstet Gynaecol 2008;22:251–60.
- Bäckström T, Andreen L, Birzniece V, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003;17:325–42.
- Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health 2010;13:485–94.
- Campagne D, Campagne G. The premenstrual syndrome revisited. Eur J Obstet Gynecol Reprod Biol 2007;130:4–17.
- Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psycho-neuroendocrinology 2003;3:39–53.
- Kidd P. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 2007;3:207–27.
- Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 2003;69:477–85.
- Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the Seven Countries Study population of Crete. Prostaglandins Leukot Essent Fatty Acids 2004;70:495–501.
- Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. Eur Neuropsy-chopharmacol 2003;13:267–71.
- Sohrabi N, Kashanian M, Ghafoori SS, Malakouti SK. Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: syndrome: “a pilot trial”. Complement Ther Med 2013;21:141–6.
- Collins A, Cerin A, Coleman G, Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81:93–8.
- Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int 2012;18:48–51.
- Hariri F, Moghaddam-Banaem L, Siah Bazi S, et al. The Iranian version of the premenstrual symptoms screening tool (PSST): a validation study. Arch Womens Ment Health 2013;16:531–7.
- Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003;6:203–9.
- Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item short form health survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health 2009;9:341–51.
- Hróbjartsson A, Gøtzsche P. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;44:1594–602.
- Rocha Filho EA, Lima JC, Pinho Neto JS, Montarroyos U. Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study. Reprod Health 2011;8:2.
- Cerin A, Collins A, Landgren BM, Eneroth P. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstet Gynecol Scand 1993;72:337–43.
- Makrides M, Gibson RA, McPhee AJ, DOMInO Investigative Team, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304:1675–83.
- Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007;137:855–9.